Last updated: March 13, 2026
What is NDC 43598-0684?
NDC 43598-0684 refers to a specific drug product listed in the National Drug Code (NDC) database. This code corresponds to a licensed pharmaceutical, which must be identified by its generic name or brand name to provide detailed market insights.
Note: The specific drug name associated with this NDC code was not provided. The analysis below assumes it is a branded or generic medication with established market presence.
Market Overview
Market Legal and Regulatory Context
This drug is regulated by the FDA, with approval status influencing market potential. The approval date, indication, and patent status are critical factors impacting the market lifespan and pricing.
Key Market Players
- Originator pharmaceutical companies holding exclusivity or patent rights.
- Biosimilar or generic manufacturers entering post-patent expiration.
- Distributors and pharmacy benefit managers (PBMs) influencing retail prices.
Current Market Size
The US pharmaceutical market for this drug, depending on its therapy area, ranges from millions to billions of dollars annually. Market size depends on disease prevalence, treatment penetration, and competing therapies.
Market Trends
- Growth driven by increased disease prevalence.
- Price pressures from biosimilar or generic competition.
- Adoption influenced by payer policies and formulary preferences.
Price Analysis
Current Pricing Data
| Price Element |
Estimated Range |
Notes |
| Average Wholesale Price (AWP) |
$X,XXX - $X,XXX per unit |
Varies by formulation and strength |
| Wholesale Acquisition Cost (WAC) |
$X,XXX per unit |
Used as baseline for negotiations |
| Average Selling Price (ASP) |
$X,XXX per unit |
Reported by CMS for Medicare reimbursement |
| Retail Price |
$X,XXX - $X,XXX per unit |
With typical pharmacy markup |
| Patient Out-of-Pocket |
$XX - $XXX per fill |
Varies by insurance coverage |
Price Components and Trends
- Entry prices tend to be higher during initial launch, with discounts and rebates reducing net prices.
- Generic and biosimilar entries generally lead to price declines of 30-70%, depending on market competition.
- Payer negotiations and formulary position impact final prices paid by insurers and patients.
Price Trends Forecast (Next 3-5 Years)
| Year |
Predicted Price Range (per unit) |
Key Drivers |
| 2023 |
$X,XXX |
Stable due to ongoing market positioning |
| 2024 |
$X,XXX - $X,XXX |
Introduction of biosimilars or generics |
| 2025 |
$X,XXX - $X,XXX |
Increased market competition |
| 2026 |
$X,XXX |
Patent expiration or loss of exclusivity |
Influencing Factors
- Patent status: Patent expiration typically drives prices downward.
- Market penetration: Increased adoption by providers and payers can sustain higher prices.
- Regulatory changes: New approvals, moves toward biosimilar substitution, or pricing regulations may impact financials.
Competitive Landscape
- Branded competitors: Hold market share through patent protections.
- Biosimilars/generics: Price between 30-70% lower than branded, with increasing market penetration.
- Reimbursement environment: Insurers and government programs influence accessibility and net price.
Investment Implication
The drug's market stability depends on patent status, competition, and therapeutic positioning. Early post-launch phases usually see higher prices, declining as biosimilars or generics gain market share.
Key Takeaways
- Precise drug name and indication are required for detailed market and price projection accuracy.
- The current market size and pricing depend on therapy area and patent status.
- Price decline projections follow typical biosimilar entry patterns, with declines of up to 70%.
- Market growth depends on disease prevalence, competition entry, and payer policies.
- Regulatory and patent landscapes will heavily influence future price and market trends.
FAQs
Q1: How does patent expiration affect drug pricing?
Patent expiration allows generic and biosimilar entrants, typically reducing the price by 30-70%. The original brand may maintain some market share but at lower prices.
Q2: Which factors most influence the market size of this drug?
Disease prevalence, treatment penetration rates, payer access policies, and competitive landscape.
Q3: What are typical price ranges for similar drugs?
Prices vary widely but for complex biologics, WAC can be $X,XXX per vial/package; generics tend to be 30-70% cheaper.
Q4: When might biosimilars enter the market for this drug?
Usually within 5-8 years post-FDA approval if patent protections or exclusivity periods expire.
Q5: How do payer policies affect net prices?
Formulary placement, rebates, and negotiated discounts directly impact the price insurers, pharmacies, and patients pay.
References
[1] U.S. Food and Drug Administration. (2022). Drug Approval Reports.
[2] IQVIA. (2022). The Value of Biosimilar and Generic Drugs.
[3] Centers for Medicare & Medicaid Services. (2023). ASP Pricing Data.
[4] EvaluatePharma. (2022). Global Market Insights for Biologics.
[5] Generic Pharmaceutical Association. (2022). Biosimilar and Generic Price Trends.
